¥842.44
Below FV▲ +38.6% against the close used
Model range ¥551.16 – ¥1,310.10
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear¥551.16Fair value¥842.44Bull¥1,310.10
FairClose
52-week traded range
52W low ¥577.0052W high ¥765.00
The 52-week range is measured from the stored price history, not estimated.
Trading below the consensus fair value
Human Metabolome Technologies,Inc. closed at ¥608.00, 27.8% below the consensus fair value of ¥842.44 drawn from 9 valuation models.
Financial DNA score 75/100 — Strong. P/E of 13.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
¥759.89
+25.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥571.36
-6.0%
√(22.5 × EPS × BVPS)
EPS=43.67, BVPS=332.24 · outside Graham range (P/E 13.9, P/B 1.8) — asset-light, treat as a rough floor
P/E Fair Value
¥873.40
+43.7%
EPS × 20x (sector P/E)
EPS=43.67, Sector P/E=20x
Peter Lynch (PEG)
¥1,310.10
+115.5%
EPS × Growth% (PEG = 1 is fair)
EPS=43.67, g=30%
EV/EBITDA
¥1,066.12
+75.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=353.33M
Dividend Discount (DDM)
¥810.95
+33.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=15.02, r=10%, g=8%
Book Value (P/B)
¥631.26
+3.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=332.24, ROE=13.6%, g=6%, r=10%
Reverse DCF
¥608.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 2.2% | Historical: 44.9%
Margin of Safety
¥551.16
-9.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=734.88, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.